144 related articles for article (PubMed ID: 17239163)
1. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements.
Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Biesma DH; Mauser-Bunschoten EP
Haemophilia; 2012 May; 18(3):e266-72. PubMed ID: 22103568
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders.
Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Mauser-Bunschoten EP
Haemophilia; 2011 Sep; 17(5):e975-80. PubMed ID: 21535322
[TBL] [Abstract][Full Text] [Related]
4. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
[TBL] [Abstract][Full Text] [Related]
5. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.
Fransen van de Putte D; Blom R; van Soest H; Mundt M; Verveer C; Arends J; de Knegt RE; Mauser-Bunschoten E; van Erpecum K
Ann Hepatol; 2011; 10(4):469-76. PubMed ID: 21911887
[TBL] [Abstract][Full Text] [Related]
6. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS;
J Acquir Immune Defic Syndr; 2020 Dec; 85(5):e81-e89. PubMed ID: 32842055
[TBL] [Abstract][Full Text] [Related]
8. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
9. Comparison of liver biopsy and transient elastography based on clinical relevance.
Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Goto T; Yoshida H; Kanai F; Sugioka Y; Ikeda H; Shiina S; Kawabe T; Omata M
Can J Gastroenterol; 2008 Sep; 22(9):753-7. PubMed ID: 18818788
[TBL] [Abstract][Full Text] [Related]
10. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
[TBL] [Abstract][Full Text] [Related]
11. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
[TBL] [Abstract][Full Text] [Related]
12. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
13. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
14. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis.
Wang JH; Changchien CS; Hung CH; Eng HL; Tung WC; Kee KM; Chen CH; Hu TH; Lee CM; Lu SN
J Gastroenterol; 2009; 44(5):439-46. PubMed ID: 19308312
[TBL] [Abstract][Full Text] [Related]
15. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
[TBL] [Abstract][Full Text] [Related]
17. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
Ziol M; Handra-Luca A; Kettaneh A; Christidis C; Mal F; Kazemi F; de Lédinghen V; Marcellin P; Dhumeaux D; Trinchet JC; Beaugrand M
Hepatology; 2005 Jan; 41(1):48-54. PubMed ID: 15690481
[TBL] [Abstract][Full Text] [Related]
19. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
